Safety and Pharmacokinetics of FMX103 (1.5% Minocycline Topical Foam) in Subjects with Moderate-to-Severe Papulopustular Rosacea under Maximum-use Treatment Conditions March 1, 2021 J Clin Aesthet Dermatol. 2021;14(3):E53–E57. by Terry M. Jones, MD, and Iain CONTINUE READING »
